AQUAMEPHYTON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aquamephyton, and what generic alternatives are available?
Aquamephyton is a drug marketed by Pai Holdings Pharm and is included in one NDA.
The generic ingredient in AQUAMEPHYTON is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aquamephyton
A generic version of AQUAMEPHYTON was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.
Summary for AQUAMEPHYTON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Patent Applications: | 3,627 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AQUAMEPHYTON at DailyMed |
US Patents and Regulatory Information for AQUAMEPHYTON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pai Holdings Pharm | AQUAMEPHYTON | phytonadione | INJECTABLE;INJECTION | 012223-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pai Holdings Pharm | AQUAMEPHYTON | phytonadione | INJECTABLE;INJECTION | 012223-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |